Global Anti-Infective Agents Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast: 2019–2028
“Global Anti-Infective Agents Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global anti-infective agents market report has been segmented on the basis of type, indication, distribution channel, and region.
Global Anti-Infective Agents Market: Overview
Anti-infective agents are drugs used to prevent infectious organisms or agents by inhibiting or killing in order to prevent the spreading the infection, prior to their discovery agents such as mercury and arsenic. In which, the infection causing micro-organisms includes virus, bacteria, viroid’s, fungi, and macroparasites.
Global Anti-Infective Agents Market: Dynamics
increasing the number of aging population coupled with rising prevalence of infectious diseases such as H1N1, HIV, and Ebola virus are primary factors expected to boost demand for anti-infective agents over the forecast period. In addition, increasing demand for anti-infective drugs across the globe owing to rising frequency rates of irresistible sicknesses is another factor estimated to drive the growth of the anti-infective agent’s market. Development of new multi-drug resistance against micro-organisms is another factor expected to propel the global anti-infective agent’s market.
Factors projected to restrain the growth of the global anti-infective agent’s market includes high research and development cost, competition among generic manufacturers, and lack of awareness in developing regions.
Moreover, growing technological advancements in the healthcare infrastructure and rising funding from the government for the R&D activities related to the development of new drugs are expected to create lucrative growth opportunities in the global anti-infective agent’s market.
Global Anti-Infective Agents Market: Segment Analysis
Among the type segments, the antiviral segment is projected to register moderate growth rate in the global anti-infective agent’s market. The antibacterial segment is projected to register the significant growth in the coming year, owing to the availability of the antibacterial agents as compared to other agents.
Among the indication segments, the pneumonia segment is projected to register moderate growth rate in the global market.
Among the distribution channel segments, the hospital pharmacy segment is expected to account for a major share in the global market. Whereas, the online sales segment is projected to be the fastest growing segment in the global anti-infective agent’s market, owing to convenience, flexibility, and comfort for consumers as compared to other distribution channels.
Global Anti-Infective Agents Market: Region Analysis
The market in North America is expected to account for the highest revenue share in the global market, followed by Europe. Increasing aging population, growing incidence of infectious diseases, and availability of non-prescription anti-infective agents is projected to drive the growth of the anti-infective agents market in North America. In addition, the favorable reimbursement policies from governments of countries in this region is estimated to drive the growth of the North America anti-infective agent’s market.
Asia Pacific market is expected to register a significant growth rate in the global market, owing to the rapid development of healthcare infrastructure, and rising awareness in healthcare professionals and patient pool support the rapid growth of the market in this region.
Global Anti-Infective Agents Market Segmentation:
Segmentation by Type:
Segmentation by Indication:
- Hepatitis Virus Infection
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- HIV Infection
- Respiratory Virus Infection
Segmentation by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- GlaxoSmithKline plc.
- Pfizer Inc.
- Bayer AG
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Abbott India Limited
- Novartis AG
- Johnson & Johnson Services Inc.
- Gilead Sciences, Inc.
- Astellas Pharma Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!